Analysis of FDA reports finds Prozac’s sexual side effects vary widely, with some emerging years into treatment

A recent study published in Progress in Neuropsychopharmacology & Biological Psychiatry sheds light on the highly variable sexual side effects associated with the antidepressant fluoxetine. Using advanced computer modeling, researchers discovered that fluoxetine may interfere with immune and cellular stress proteins, hinting at the biological mechanisms behind these symptoms.

Fluoxetine is a widely prescribed medication for depression and anxiety and belongs to the selective serotonin reuptake inhibitor (SSRI) class. These drugs work by increasing serotonin availability in the brain, which regulates mood. While effective for mental health conditions, they often produce unwanted sexual side effects. The investigation, led by researchers from Nanchang University in China, aimed to better understand these adverse reactions.

Previous studies attributed these side effects primarily to enhanced serotonin activity suppressing other brain chemicals like dopamine, which drives sexual arousal. However, this study suggests that other biological networks, including inflammation and cell survival pathways, might also play a role. The researchers analyzed data from the FDA Adverse Event Reporting System, a public database that collects voluntary reports of adverse drug reactions from patients and healthcare professionals.

They extracted records from 2004 to 2025 containing fluoxetine as the primary suspected drug and analyzed 997 reports related to sexual dysfunction. The analysis revealed strong statistical signals for a wide range of sexual problems, including erectile dysfunction and decreased libido, as well as highly specific conditions such as inability to climax, decreased orgasmic sensation, and genital numbness.

The timing of these side effects varied greatly, with some conditions appearing within the first few days of treatment, while others emerged after more than two years of continuous medication use. The study also identified two core hub proteins, IL10 and TP53, that fluoxetine chemically binds to, potentially altering their function and contributing to sexual side effects.

However, the limited nature of the FDA database, relying on voluntary submissions and lacking complete information on drug dosages, treatment duration, and patients' other medications, makes it difficult to determine the exact dosage required to trigger specific symptoms.